7,075 press releases indexed under healthcare.
CEO Michael Halstead to participate in a fireside chat on Friday, September 11, 2026 at 8:00 a.m. EDT. CEO Michael Halstead to participate in a fireside chat on Friday, September 11, 2026 at 8:00 a.m. EDT.
Report analyzes 12 months of provider directory audits and millions of provider records to identify systemic data quality challenges and outline a roadmap for operational improvement. LANGHORNE, Pa., Sept. 3, 2026 /PRNewswire/ -- Perspecta today announced the release of The State of...
NEW HAVEN, Conn., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF), non-IPF interstitial lung disease (non-IPF ILD), and refractory chronic cough (RCC), today announced that senior management will participate in the following conferences in September.
Shanghai, China--(Newsfile Corp. - September 3, 2026) - Frost & Sullivan, in partnership with TradeGo, LeadLeo and CCXGF (China Chengxin Green Finance Technology (Beijing) Ltd.), officially unveils the 2026 Blue Book on the Development of Hong Kong Stock Exchange 18A Biotech Sector, delivering an in-depth panorama of the Hong-Kong 18A biotech ecosystem, capital market cycles, innovative drug R&D breakthroughs, enterprise commercialization progress and global expansion trends. The report serves...
(PR-inside.com) Cellgenic is expanding local representation and commercial support in Brazil, one of Latin America's larger healthcare and aesthetic-medicine markets. ISSCA continues to hold physician-education events in São Paulo. Activities in Brazil remain subject to applicable local law and regulatory requirements. MIAMI, FL / ACCESS Newswire / September 3, 2026 / Regenerative Medical Technology Group Inc. (the "Company" or "RMTG") (OTCID:RMTG), a regenerative medicine company operating through its wholly owned subsidiary Global Stem Cells Group, today announced that its Cellgenic division has expanded its commercial presence in Brazil through local representation, physician-facing commercial support, and related infrastructure intended to support product distribution ..
Toronto, Ontario--(Newsfile Corp. - September 3, 2026) - Cybeats Technologies Corp. (CSE: CYBT) (OTCQB: CYBCF) ("Cybeats" or the "Company"), a leader in software supply chain security, today announced a 76% revenue expansion of its existing six-figure commercial engagement with a global medical device manufacturer for SBOM Studio. The expansion reflects the continued adoption of Cybeats' platform across the customer's software security program. The renewed engagement also includes the onboarding...
Vancouver, British Columbia--(Newsfile Corp. - September 3, 2026) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE: X8F) ("DiagnosTear" or the "Company"), a developer of innovative point-of-care eye diagnostic solutions, is pleased to announce the submission of a pre-submission request to the U.S. Food and Drug Administration ("FDA") for its TeaRx™ Red Eye diagnostic test (the "Pre-Submission").The Pre-Submission represents an important regulatory milestone in the Company's U.S. development...
Fistula Foundation today launched the Fistula Foundation Treatment Network (FFTN) in Uganda, in partnership with the Ministry of Health and seven implementing partners in Uganda. SOROTI, Uganda, Sept. 3, 2026 /PRNewswire-PRWeb/ -- Fistula Foundation today launched the Fistula Foundation...
ZUG, Switzerland, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated angioedema, such as hereditary angioedema (HAE) and acquired angioedema due to C1 inhibitor deficiency (AAE-C1INH), summarized the oral and poster presentations from the Bradykinin Symposium 2026, which will take place from September 3-4, 2026, in Berlin, Germany.
(PR-inside.com) Agreement with Spartan Medical opens adds a channel to the U.S. government healthcare market, supplementing existing U.S. commercial distribution and 18 foreign countries. WESTMINSTER, CA / ACCESS Newswire / September 3, 2026 / BioLargo, Inc. (OTCQX:BLGO), a cleantech and life sciences company, today announced that its subsidiary Clyra Medical Technologies is expanding distribution of its FDA-cleared ViaCLYR™ wound irrigation solution through a new Reseller Agreement with Spartan Medical Inc., opening a dedicated commercial channel to U.S. government healthcare facilities worldwide. BioLargo CEO Dennis Calvert commented, "This third reseller agreement for Clyra's ViaClyr opens a direct path for federal government purchasing and distribution. ..
Agreement with Spartan Medical opens adds a channel to the U.S. government healthcare market, supplementing existing U.S. commercial distribution and 18 foreign countries.
Sandra Chavarria has completed a stirring book, titled, "Rescued," which chronicles her harrowing battle with COVID-19 during the pandemic's earliest and most devastating wave. Found unresponsive and deprived of oxygen to her brain, Sandra was placed on life support with medical professionals offering little hope for recovery. Yet what unfolded over thirteen months defied every clinical expectation, revealing [PR.com]